Slideshow
Author(s):
Pain related to more severe motor symptoms, phosphodiesterase 10A loss seen early, novel therapy shows promise, and other recent findings are summarized here.
GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
This Week on NeurologyLive® — April 21, 2025
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
A Clinician’s Perspective on First-in-Human Data for LRRK2 Degrader ARV-102
Felix NeuroAI Wristband Demonstrates Superiority Over Sham Device in TRANQUIL Study for Essential Tremor